You are here

Article Text

Article menu
Download PDFPDF
Point-Counterpoint
Introduction to Point–Counterpoint
  1. Kristine A Blackham
  1. Correspondence to Dr Kristine A Blackham, University Hospitals Dept of Radiology, Case Western Reserve University, 11100 Euclid Ave, Cleveland 44106, Ohio, USA; kristine.blackham{at}uhhospitals.org

https://doi.org/10.1136/neurintsurg-2012-010268

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the second edition of ‘Point-Counterpoint’, Drs Alexander and Sila appraise a complex problem which runs the gamut of ‘hot topics’ from study design and technical expertise to reimbursement and pertinence of study data to the greater medical community. The issue of stenting for intracranial atherosclerotic disease received media attention in 2011, once the results of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) trial became available, precipitating a decline in procedure referrals as an immediate clinical impact as well as an uproar of debate. SAMMPRIS was the first stroke prevention trial comparing intracranial stenting with medical therapy and the …

    View Full Text

    Footnotes

    • Linked articles 010269, 010270.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles